Toxoid-Vaccines
发表于 2025-3-28 14:48:28
Chronic Lung Allograft Dysfunction: Phenotypes and the Future,erans syndrome (BOS)) remains the major barrier to long-term survival after lung transplantation. CLAD affects approximately 10% of patients each year and has proven a particularly difficult problem to address, with no major improvements in survival for 3 decades. In this chapter, current diagnostic
ELUC
发表于 2025-3-28 19:41:59
http://reply.papertrans.cn/32/3156/315579/315579_42.png
诱惑
发表于 2025-3-28 23:51:09
Lung Transplantation for Obstructive Lung Diseases,unique challenges. Unlike the fibrotic conditions, obstructive lung diseases may have a more indolent course, and so timing of listing and transplantation becomes increasingly relevant. Given the variable natural history and progression of COPD, the use of functional assessments and use of multivari
符合你规定
发表于 2025-3-29 05:54:48
http://reply.papertrans.cn/32/3156/315579/315579_44.png
neolith
发表于 2025-3-29 07:15:22
http://reply.papertrans.cn/32/3156/315579/315579_45.png
水汽
发表于 2025-3-29 12:06:11
How to Measure Success,al rate for patients post lung transplant is 6.0 years however this rate varies according to primary diagnosis and type of transplant. For certain conditions such as emphysema the survival benefit of transplantation remains unclear. Hence the potential improvement in quality of life becomes a drivin
ECG769
发表于 2025-3-29 19:18:40
http://reply.papertrans.cn/32/3156/315579/315579_47.png
pacific
发表于 2025-3-29 21:59:48
Rolf M. Zinkernagel,Peter C. Dohertylung transplantation have increased significantly over the last 10 years with Chronic Obstructive pulmonary disease, Idiopathic pulmonary fibrosis and Cystic Fibrosis being the main indications..Through experience and research, it is now apparent that the underlying severity of the lung condition sh
吞下
发表于 2025-3-30 01:27:05
http://reply.papertrans.cn/32/3156/315579/315579_49.png
Externalize
发表于 2025-3-30 06:15:05
http://reply.papertrans.cn/32/3156/315579/315579_50.png